Form 4 for CORT CORCEPT THERAPEUTICS INC
Accepted 2024-09-05 00:00:00 ET · period of report 2024-09-03 · accession 0000950170-24-104196 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-09-05 | 2024-09-03 | CORT | Guyer William | Chief Development Off | F - Tax | $35.30 | -243 | 5,796 | -4% | -$8,578 |
| DT | 2024-09-05 | 2024-09-03 | CORT | Guyer William | Chief Development Off | M - OptEx | $21.65 | +10.0K | 16.0K | +166% | +$216.5K |
| DT | 2024-09-05 | 2024-09-03 | CORT | Guyer William | Chief Development Off | S - Sale+OE | $35.30 | -10.0K | 6,039 | -62% | -$353.0K |
| DT | 2024-09-05 | 2024-09-03 | CORT | Guyer William | Chief Development Off | M - OptEx | $0.00 | -10.0K | 470.0K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-03 | F | D | 243 | $35.30 | 5,796 | D | — | — | (F4) The closing price on August 30, 2024 was used to calculate the withholding obligation. (F1) Includes 609 shares underlying unvested restricted stock units granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. |
| 2 | Common | Common Stock | 2024-09-03 | M | A | 10,000 | $21.65 | 16,039 | D | — | — | (F1) Includes 609 shares underlying unvested restricted stock units granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. |
| 3 | Common | Common Stock | 2024-09-03 | S | D | 10,000 | $35.30 | 6,039 | D | — | — | (F1) Includes 609 shares underlying unvested restricted stock units granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. |
| 4 | Derivative | Stock option (right to buy) | 2024-09-03 | M | D | 10,000 | $0.00 | 470,000 | D | $21.65 · — to 2031-09-01 | 10,000 Common Stock | (F5) Shares subject to the stock option vested and became exercisable with respect to 25% of the shares on the first anniversary of August 16, 2021 (the "Vesting Commencement Date") with the remaining shares vesting and becoming exercisable ratably on a monthly basis over a period of 36 consecutive months thereafter until fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service. |